The main goal of this study was to identify the principal characteristics that differentiate a family with BRCA1/BRCA2 pathogenic mutations from those with a VUS alteration and even from those BRCA1/BRCA2 WT and with sporadic breast tumors. The gene discussed is BRCA1; the disease is breast neoplasm.